Báo cáo khoa học: "Drotrecogin alfa (activated) should not b

Báo cáo khoa học: "Drotrecogin alfa (activated) should not be used in patients with severe sepsis and low risk for death" pdf

... children with severe sepsis, and in patients receiving low- dose heparin [3]. In the Administration of Drotrecogin Alfa (Activated) in Early Stage Severe Sepsis (ADDRESS) study [1], Abraham and ... with the ADDRESS authors. DrotAA should not be used in patients with severe sepsis and low risk for death. Competing interests The auth...

Ngày tải lên : 13/08/2014, 03:20

3
295
0

Báo cáo khoa học: "Afelimomab led to a modest mortality benefit in patients with severe sepsis and elevated interleukin-6 leves" pptx

... double-blind, randomized controlled trial in severe sepsis completed to date. Follow- up was complete in all patients and co-interventions, such as adequate antibiotic therapy, surgical interventions, ... as drotrecogin alfa (activated) or steroids [6], leads to additional mortality benefits in severe sepsis. Competing interests The authors declare that they have n...

Ngày tải lên : 12/08/2014, 22:22

2
202
0

Báo cáo y học: "The effects of IgM-enriched immunoglobulin preparations in patients with severe sepsis: another point of view" pot

... some definitive immunotherapy information in the near future. In our study, we have presently included 34 patients in the treatment group (IgM + IgG + IgA) and 34 in the control group. Analyzing ... decrease in our preliminary analysis) is 120 patients in each arm. In a study with a smaller number of patients, therefore, such as those of Tugrul et al. (21 patients i...

Ngày tải lên : 12/08/2014, 19:21

2
449
0

Báo cáo y học: "The effects of IgM-enriched immunoglobulin preparations in patients with severe sepsis: another point of view — authors’ respons" pps

Ngày tải lên : 12/08/2014, 19:21

1
274
0

Báo cáo y học: " Treatment effects of recombinant human soluble thrombomodulin in patients with severe sepsis: a historical control study" docx

... DC, Helterbrand JD, Levy H, Dhainaut JF, Vincent JL, Macias WL, Bernard GR: Drotrecogin alfa (activated) administration across clinically important subgroups of patients with severe sepsis. Crit ... prevents endotoxin-induced pulmonary vascular injury in rats by inhibit ing pulmonary accumulation of leukocytes through thrombin binding and subsequent protein C activation. Th...

Ngày tải lên : 14/08/2014, 08:21

10
215
0

Báo cáo khoa học: "Drotrecogin alfa (activated) in patients with severe sepsis presenting with purpura fulminans, meningitis, or meningococcal disease: a retrospective analysis of patients enrolled in recent clinical studies" ppt

... 4 Research Drotrecogin alfa (activated) in patients with severe sepsis presenting with purpura fulminans, meningitis, or meningococcal disease: a retrospective analysis of patients enrolled in recent clinical ... life-threatening or fatal events) com- pared with patients without PF, MEN, or MD. Adult, but not pediatric, patients with MEN seemed at increased...

Ngày tải lên : 12/08/2014, 22:21

13
361
0

Báo cáo khoa học: "Drotrecogin alfa (activated): down and not out, but not really in eithe" ppt

... conservative random-effects model, which includes it. Such a model shows significant benefit for DrotAA in patients with severe sepsis and at a high risk of death defined either by an Acute Physiology and ... treatment effect between high -risk and low- risk subgroups in PROWESS was not statistically significant (for example, patients with multiple organ failu...

Ngày tải lên : 13/08/2014, 03:20

2
340
0

Báo cáo khoa học: "Drotrecogin alfa (activated): current evidence supports treatment for severe sepsis patients with a high risk of death" ppsx

... et al., for the Administration of Drotrecogin alfa (activated) in Early Stage Severe Sepsis (ADDRESS) Study Group: Drotrecogin alfa (activated) for adults with severe sepsis and a low risk of ... Ely EW, et al., for the Recombinant Human Protein C Worldwide Evaluation in Severe Sepsis (PROWESS) Study Group: Efficacy and safety of recombinant human act...

Ngày tải lên : 13/08/2014, 03:20

2
211
0

Báo cáo khoa học: "Drotrecogin alfa (activated) in patients with severe sepsis and a high risk of death" ppsx

Ngày tải lên : 13/08/2014, 03:20

1
231
0

Báo cáo khoa học: " A dosimetric analysis of respiration-gated radiotherapy in patients with stage III lung cancer" pptx

... GTV mobility within the chosen gating window was 4.0 ± 3.5 mm (Table 2), and a residual GTV mobility that exceeded 5.0 mm was observed in 5 patients (33%), including 2 patients with upper lobe lesions. ... the 15 patients with tumors in upper- (n = 2), middle- (n = 2), and lower lobes (n = 3). For the upper lobe tumors, the mobility of mediastinal lymph nodes appeared to...

Ngày tải lên : 09/08/2014, 10:20

9
394
0